Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in malignant mesothelioma

Bruce W S Robinson1, Richard A Lake

  • 1School of Medicine and Pharmacology, Sir Charles Gairdner Hospital, Nedlands, Perth, Australia. bwsrobin@cyllene.uwa.edu.au

The New England Journal of Medicine
|October 14, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Scientific reports·2026
Same author

Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Vaccines·2026
Same author

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.

Oxford open immunology·2026
Same author

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.

Cell reports. Medicine·2024
Same author

Mesothelioma survival prediction based on a six-gene transcriptomic signature.

iScience·2024
Same author

Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy.

Scientific data·2024